For your chance to shape the future of how we support Commercial Research in Primary Care
If you are starting your commercial portfolio, need a refresher or want to learn more, below you can find a modular bitesize series where we discuss different aspects of the lifecycle of a commercial study.
A group of commercially active and commercially curious practices meet every 2 months on a Tuesday lunch time 1pm-2pm. Here we discuss national updates, share experiences and look in depth at new and upcoming studies. To join this group, please email em.rrdn@nihr.ac.uk >, or click here to add the meeting to your calendar. To see previous presentations, agendas and minutes please find them here.
The first meeting of the series, we will introduce commercial research, how it differs from non-commercial research and showcase the benefits of delivering a commercial study. We will also talk what it involves and the different types of commercial studies.
In this meeting, we will discuss and overview of the life-cycle of a commercial study. A step by step guide on what delivering a commercial study entails, from feasibility to study closedown.
In this meeting we will discuss how to identify a suitable study for your practice and patient population, how to submit a good expression of interest and site ID form, and general tips to increase the chances of being selected for a commercial study. Please note, if you have recently attended the "Commercial feasibility workshop" in NIHR Learn, this session will be very similar.
The fourth meeting in the series, we will discuss all documents and actions you need to do before opening a commercial study. Having templates and documents set up from the start will help with efficient communication with the study team, patients and help answer any questions the sponsor or clinical research organisation may have.
What is a Clinical Research Organisation? What is the difference between a CRO and a sponsor? In this meeting we will learn about CROs, their structure , roles and responsibilities and terminology commonly used.
In the sixth meeting of the series, we will be discussing commercial contracts. These can be found on the HRA websites and include the financial appendix with instructions on who to contact. We will also discuss financial tracking and how it differs from non-commercial studies. Please note, specific studies and financial situations cannot be discussed in this webinar. Please speak to the CRN EM for any specific questions and concerns.
What is capacity and capability and the green light process? In the seventh meeting of this series we will discuss what this process entails and how to get there, including Site Qualification Visits (SQV), Site Initiation Visits (SIV) and issuing C&C.
We will learn about:
1. Understanding NCVR
2. Escalation process
We will learn about:
Source data
Investigator Site Files (ISFs)
Monitoring visits
Case report form (CRFs)
We will learn about:
Pre-screening patients
Timings needed for a commercial study
Have contingency plans
Team communication